Advertisement

Reactions Weekly

, Volume 1777, Issue 1, pp 193–193 | Cite as

Pembrolizumab

Autoimmune diabetes: case report
Case report
  • 18 Downloads

Reference

  1. Abolhassani AR, et al. C-reactive protein as an early marker of immune-related adverse events. Journal of Cancer Research and Clinical Oncology 145: 2625-2631, No. 10, Oct 2019. Available from: URL: http://doi.org/10.1007/s00432-019-03002-1 - GermanyCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations